Workflow
中医药
icon
Search documents
固生堂11月10日斥资741.23万港元回购25万股
Zhi Tong Cai Jing· 2025-11-10 10:50
Core Viewpoint - The company, Guoshengtang (02273), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 250,000 shares at a total cost of HKD 7.4123 million [1] - The buyback price per share ranges from HKD 29.46 to HKD 29.82 [1] - The buyback is scheduled for November 10, 2025 [1]
专访香港中医医院行政总监卞兆祥:启动香港中医药发展新引擎
Zhong Guo Xin Wen Wang· 2025-11-10 08:08
中新社香港11月10日电 题:专访香港中医医院行政总监卞兆祥:启动香港中医药发展新引擎 作者 邱兆翔 韩星童 香港首家中医医院——香港中医医院投入服务在即,新上任的行政总监卞兆祥非常繁忙,但他乐在其 中,毕竟见证中医医院从概念到落地历经七载春秋,实属不易。近日,卞兆祥在紧凑行程间接受中新社 记者专访,谈及此事仍连连说着:"特别高兴"。他相信,这家医院将成为香港中医药发展的新引擎。 "香港回归祖国以来,中医药发展非常蓬勃。"卞兆祥坦言,香港特区政府在中医药教育、研究等领域的 推动力度很大,为香港中医药发展打开了全新局面。但唯独欠缺一家中医医院。 卞兆祥介绍,以往香港中医医疗服务主要集中在门诊范畴,以诊所模式运营,仅可满足基层医疗需求。 这意味着,若病人需要进一步化验检查、接受物理治疗,或同步咨询西医意见等,均需转介到其他相应 的医疗机构。 身为顶尖中医药临床研究专家,卞兆祥在香港浸会大学任教约25年,兼任该校协理副校长(临床中医 药)。在大学多年的工作经验让他意识到,临床医疗服务是中医药发展的根本,只有从临床中发现问 题、研究问题、解决问题,才能切实帮助更多病人。与他有着相似想法的人不在少数,多年来中医药业 界 ...
“丝路传针”四川中医走进埃及系列活动圆满收官
人民网-国际频道 原创稿· 2025-11-10 07:16
Core Points - The article highlights the deepening health cooperation between China and Egypt through the "Silk Road Acupuncture" training program organized by Sichuan Second Traditional Chinese Medicine Hospital [1][2] - The initiative aims to promote the internationalization of traditional Chinese medicine and enhance local medical talent in Egypt [1][2] Group 1: Training and Cultural Exchange - The training program took place from October 12 to November 6, involving two physicians, Zhao Jingjing and Wang Yi, who provided systematic teaching on acupuncture, moxibustion, and cupping techniques tailored to local health needs [1] - Bilingual teaching videos and Chinese-English reference materials were prepared to facilitate understanding and application among participants [1] Group 2: Community Engagement - The program included activities at various locations such as the Chinese Consulate in Alexandria, Cairo Chinese Cultural Center, and Suez Canal University, attracting local medical practitioners, students, and traditional medicine enthusiasts [1] - Additional health consultations and free medical services were provided to Chinese expatriates and local residents through collaboration with Egyptian Chinese community organizations [1] Group 3: Future Prospects - Sichuan Province plans to further expand the reach and depth of traditional Chinese medicine overseas, aiming for more practical cooperation projects to be implemented [2]
新时代中国调研行之文化中华|瑶医文化:走出深山守护健康
Xin Hua She· 2025-11-07 05:18
Core Viewpoint - The promotion and development of Yao medicine culture in Guangxi is being actively supported through various initiatives, including the implementation of standards and the establishment of community health services that incorporate traditional Yao medical practices [1][2][3] Group 1: Yao Medicine Cultural Development - Li Tong has dedicated years to the inheritance and development of Yao medicine culture, showcasing various traditional Yao medicinal artifacts in his studio, including a traditional "atomization" tool [1] - Guangxi has launched the "Implementation Plan for the Major Project of the Revitalization and Development of Traditional Chinese Medicine and Yao Medicine" in 2023, emphasizing the importance of Yao medicine culture [1] Group 2: Standardization and Community Health - By March 2025, Guangxi has issued two volumes of "Quality Standards for Yao Medicinal Materials," covering 314 varieties of Yao medicinal materials, including 104 traditional medicines passed down through generations [2] - The collaboration between Jinxiu Yao Autonomous County Yao Medicine Hospital and Shizhulings Community Health Service Center in 2024 aims to integrate Yao medicinal techniques into primary healthcare, highlighting the characteristics of Yao medicine as "simple, convenient, effective, and affordable" [3]
民生“医”靠加码 江苏五级中医馆增至352家
Xin Hua Ri Bao· 2025-11-06 23:16
Core Insights - Jiangsu Province has made significant advancements in grassroots traditional Chinese medicine (TCM) services, with the establishment of 352 five-level TCM clinics as of the latest evaluation [1][7] - The initiative aims to enhance the quality of TCM services, transitioning from mere availability to superior quality, as part of a four-year commitment by the provincial government [2][7] Group 1: Development of TCM Clinics - The recent evaluation by the Jiangsu Provincial Health Commission added 86 new five-level TCM clinics, reflecting an increase in service capacity [1] - The five-level TCM clinics are designed to provide high-quality TCM services, with specific standards for construction and service delivery [3] Group 2: Community Engagement and Services - Residents like Grandma Bai have benefited from personalized TCM services, including home visits from family doctor teams for chronic disease management [2][5] - The clinics offer unique services tailored to community needs, such as weight management programs and specialized treatments for conditions like lumbar disc herniation [3][4] Group 3: Accessibility and Expert Collaboration - The initiative has improved access to expert medical care, allowing residents to consult specialists from higher-tier hospitals within their communities [6] - The establishment of partnerships with tertiary hospitals has enabled the integration of expert resources into community health services [6] Group 4: Cultural Heritage and Patient Satisfaction - The five-level TCM clinics have become trusted local healthcare providers, with high patient satisfaction rates and a focus on preserving traditional TCM practices [7] - Notable practitioners, such as those practicing historical TCM techniques, have attracted patients from surrounding areas, enhancing the reputation of these clinics [6][7]
给产业痛点开个良方
Jing Ji Ri Bao· 2025-11-06 22:10
Core Insights - The key pain points in the traditional Chinese medicine (TCM) industry include high planting costs and price volatility for herbal farmers, short industry chains and weak competitiveness in major production areas, and inconsistent quality of herbal materials affecting treatment outcomes and long-term development [1][2] Group 1: Industry Challenges - High planting costs and price fluctuations are significant pain points for herbal farmers [1] - Short industry chains and weak competitiveness are challenges faced by major TCM production areas [1] - Inconsistent quality of herbal materials impacts treatment effectiveness and the long-term growth of the industry [1] Group 2: Proposed Solutions - A comprehensive approach focusing on full-chain acceleration, quality control throughout the process, and lifecycle services is suggested to reduce costs, extend chains, and improve quality for high-quality development in the TCM industry [1] - Gansu Province has made notable progress in protecting and developing TCM resources, nurturing TCM enterprises, and promoting wealth through TCM, providing useful references for addressing industry development pain points [1] Group 3: Importance of Quality - High-quality raw materials are crucial for gaining market competitiveness in any industry, including TCM [1] - Gansu, as a major production area for herbal materials, is implementing measures such as optimizing layouts, breeding quality varieties, establishing source bases, and initial processing to ensure high-quality herbal materials [1] - The development path of the full industry chain based on authentic herbal materials may be one of the effective solutions to the pain points in the TCM industry [2]
千年药乡“长”出500亿元产业链——来自甘肃省定西市的调查
Jing Ji Ri Bao· 2025-11-06 22:07
Core Viewpoint - The traditional Chinese medicine (TCM) industry in China is experiencing rapid growth, with a market size exceeding 700 billion yuan, but faces challenges such as high planting costs and quality control issues, necessitating an urgent need for a comprehensive upgrade of the entire industry chain [1] Industry Development - Gansu Province, particularly Dingxi City, is a key area for TCM resources, with a stable planting area of over 2 million mu and a total output of more than 500,000 tons [1] - The TCM industry is a strategic pillar for Dingxi, contributing significantly to local income, with farmers earning 22.4% of their disposable income from TCM-related activities [1] Standardization and Efficiency - Dingxi has implemented standardized planting practices, significantly reducing labor costs from one-third to one-tenth of income through mechanization and drone technology [3] - The establishment of a closed-loop system for quality control in TCM planting has been achieved, with 84.2% of TCM being standardized [4] Quality Assurance - Efforts to ensure the quality of TCM materials include the establishment of seed processing plants and the promotion of high-quality seed varieties, resulting in a germination rate of over 98% [4] - The introduction of the "GAP" (Good Agricultural Practices) standard has led to the establishment of 33.02 million mu of compliant TCM bases in Gansu, maintaining a leading position nationally [8] Market and Trade - Dingxi's TCM market has a static storage capacity of 1.4 million tons, with annual trading volumes exceeding 150 million tons and transaction values nearing 30 billion yuan [12] - The establishment of processing workshops and the integration of TCM production and trade have enhanced local economic benefits, with companies like Gansu Tianceng Xingwei Pharmaceutical Co., Ltd. leading the way in the full industry chain development [7][14] Innovation and Product Development - Companies are increasingly focusing on the development of health products, with Gansu Weishuiyuan Pharmaceutical Technology Co., Ltd. expanding its product line to include health series products, contributing to 10% of its sales revenue [15] - The introduction of AI technology in production processes has improved efficiency by 50%, allowing for precise control over product quality [15] Investment and Future Prospects - Recent trade fairs have resulted in significant investment agreements, with 68 projects signed worth 8.966 billion yuan, indicating strong future growth potential in the TCM sector [16]
固生堂(02273)11月6日斥资约1376.99万港元购回49.35万股股份
智通财经网· 2025-11-06 09:42
Core Viewpoint - The company, Gushengtang (02273), announced a share buyback plan, indicating a strategic move to enhance shareholder value through repurchasing shares at a price range of 27.74 to 28.2 HKD per share [1] Group 1 - The company will spend approximately 13.7699 million HKD to repurchase 493,500 shares [1]
直播预告:听懂“脾语” 备战“冬藏”
Ren Min Wang· 2025-11-05 02:12
Core Insights - The article emphasizes the importance of understanding the health of the spleen and stomach in traditional Chinese medicine, especially as the seasons change from autumn to winter [1] - It highlights the impact of modern lifestyle and dietary habits on digestive health, noting common issues such as bloating and loss of appetite [1] Group 1: Event Details - A live discussion will take place on November 7 at 16:00, featuring experts in the field of spleen and stomach health [1] - The discussion will be led by Du Hongbo, the director of the Spleen and Stomach Disease Department at Beijing Dongzhimen Hospital, and Ruan Yun, a national old medicine worker and inheritor of intangible cultural heritage [1][2] Group 2: Expert Profiles - Du Hongbo is a chief physician and doctoral supervisor, holding several key positions in various Chinese medicine associations related to spleen and stomach diseases [2] - Ruan Yun has 33 years of experience in drug production and has established a national old medicine worker inheritance studio, serving as a guiding teacher [2]
固生堂(02273)11月4日斥资1087.31万港元回购38.05万股
智通财经网· 2025-11-04 10:26
Core Viewpoint - The company, Gushengtang (02273), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Categories Company Actions - Gushengtang plans to repurchase 380,500 shares at a total cost of HKD 10.8731 million [1] - The buyback price per share ranges from HKD 28.3 to HKD 28.74 [1]